261 related articles for article (PubMed ID: 21482963)
1. Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization.
Wu L; Ma J; Li H; Wang C; Grandi E; Zhang P; Luo A; Bers DM; Shryock JC; Belardinelli L
Circulation; 2011 Apr; 123(16):1713-20. PubMed ID: 21482963
[TBL] [Abstract][Full Text] [Related]
2. Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heart.
Wu L; Rajamani S; Li H; January CT; Shryock JC; Belardinelli L
Am J Physiol Heart Circ Physiol; 2009 Sep; 297(3):H1048-57. PubMed ID: 19592609
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of physiological late Na
El-Bizri N; Li CH; Liu GX; Rajamani S; Belardinelli L
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H236-H245. PubMed ID: 28971840
[TBL] [Abstract][Full Text] [Related]
4. Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine.
Wu L; Guo D; Li H; Hackett J; Yan GX; Jiao Z; Antzelevitch C; Shryock JC; Belardinelli L
Heart Rhythm; 2008 Dec; 5(12):1726-34. PubMed ID: 19084812
[TBL] [Abstract][Full Text] [Related]
5. Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes.
Song Y; Shryock JC; Wu L; Belardinelli L
J Cardiovasc Pharmacol; 2004 Aug; 44(2):192-9. PubMed ID: 15243300
[TBL] [Abstract][Full Text] [Related]
6. Effects of ranolazine on torsades de pointes tachycardias in a healthy isolated rabbit heart model.
Sossalla S; Wallisch N; Toischer K; Sohns C; Vollmann D; Seegers J; Lüthje L; Maier LS; Zabel M
Cardiovasc Ther; 2014 Aug; 32(4):170-7. PubMed ID: 24785406
[TBL] [Abstract][Full Text] [Related]
7. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.
Belardinelli L; Liu G; Smith-Maxwell C; Wang WQ; El-Bizri N; Hirakawa R; Karpinski S; Li CH; Hu L; Li XJ; Crumb W; Wu L; Koltun D; Zablocki J; Yao L; Dhalla AK; Rajamani S; Shryock JC
J Pharmacol Exp Ther; 2013 Jan; 344(1):23-32. PubMed ID: 23010360
[TBL] [Abstract][Full Text] [Related]
8. Late na(+) current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model.
Antoons G; Oros A; Beekman JD; Engelen MA; Houtman MJ; Belardinelli L; Stengl M; Vos MA
J Am Coll Cardiol; 2010 Feb; 55(8):801-9. PubMed ID: 20170820
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome.
Wu L; Shryock JC; Song Y; Li Y; Antzelevitch C; Belardinelli L
J Pharmacol Exp Ther; 2004 Aug; 310(2):599-605. PubMed ID: 15031300
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade.
Jia S; Lian J; Guo D; Xue X; Patel C; Yang L; Yuan Z; Ma A; Yan GX
Br J Pharmacol; 2011 Sep; 164(2):308-16. PubMed ID: 21182492
[TBL] [Abstract][Full Text] [Related]
11. Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.
Sicouri S; Timothy KW; Zygmunt AC; Glass A; Goodrow RJ; Belardinelli L; Antzelevitch C
Heart Rhythm; 2007 May; 4(5):638-47. PubMed ID: 17467634
[TBL] [Abstract][Full Text] [Related]
12. Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current.
Undrovinas AI; Belardinelli L; Undrovinas NA; Sabbah HN
J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1(Suppl 1):S169-S177. PubMed ID: 16686675
[TBL] [Abstract][Full Text] [Related]
13. Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.
Fabritz L; Damke D; Emmerich M; Kaufmann SG; Theis K; Blana A; Fortmüller L; Laakmann S; Hermann S; Aleynichenko E; Steinfurt J; Volkery D; Riemann B; Kirchhefer U; Franz MR; Breithardt G; Carmeliet E; Schäfers M; Maier SK; Carmeliet P; Kirchhof P
Cardiovasc Res; 2010 Jul; 87(1):60-72. PubMed ID: 20110334
[TBL] [Abstract][Full Text] [Related]
14. Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.
Burashnikov A; Pourrier M; Gibson JK; Lynch JJ; Antzelevitch C
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):400-8. PubMed ID: 22322366
[TBL] [Abstract][Full Text] [Related]
15. Reverse rate-dependent changes are determined by baseline action potential duration in mammalian and human ventricular preparations.
Bárándi L; Virág L; Jost N; Horváth Z; Koncz I; Papp R; Harmati G; Horváth B; Szentandrássy N; Bányász T; Magyar J; Zaza A; Varró A; Nánási PP
Basic Res Cardiol; 2010 May; 105(3):315-23. PubMed ID: 20127488
[TBL] [Abstract][Full Text] [Related]
16. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
[TBL] [Abstract][Full Text] [Related]
17. [Involvement of veratridine-induced increase of reverse Na(+)/Ca(2+) exchange current in intracellular Ca(2+) overload and extension of action potential duration in rabbit ventricular myocytes].
Kong LH; Ma JH; Zhang PH; Luo AT; Zhang S; Ren ZQ; Feng J; Chen JL
Sheng Li Xue Bao; 2012 Aug; 64(4):433-43. PubMed ID: 22907304
[TBL] [Abstract][Full Text] [Related]
18. Balance Between Rapid Delayed Rectifier K
Hegyi B; Chen-Izu Y; Izu LT; Rajamani S; Belardinelli L; Bers DM; Bányász T
Circ Arrhythm Electrophysiol; 2020 Apr; 13(4):e008130. PubMed ID: 32202931
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent.
Antzelevitch C; Belardinelli L; Wu L; Fraser H; Zygmunt AC; Burashnikov A; Di Diego JM; Fish JM; Cordeiro JM; Goodrow RJ; Scornik F; Perez G
J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S65-83. PubMed ID: 15378132
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
Fredj S; Sampson KJ; Liu H; Kass RS
Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
